Evidence map›Paper›PMID 35273500›Full record

ArticleFrontiers in pharmacology2022

Metabolomic Impact of Lidocaine on a Triple Negative Breast Cancer Cell Line.

Thiên-Nga Chamaraux-Tran, Marie Muller, Julien Pottecher, Pierre A Diemunsch, Catherine Tomasetto, Izzie-Jacques Namer, Nassim Dali-Youcef

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Targeted Delivery of Lidocaine in Breast Cancer Cells via Zeolitic Imidazolate Framework-8 Nanoparticles.Chemphyschem : a European journal of chemical physics and physical chemistry · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Thiên-Nga Chamaraux-TranService d'anesthésie-réanimation et Médecine Périopératoire, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Marie MullerService d'anesthésie-réanimation et Médecine Périopératoire, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Julien PottecherService d'anesthésie-réanimation et Médecine Périopératoire, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Pierre A DiemunschService d'anesthésie-réanimation et Médecine Périopératoire, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Catherine TomasettoInstitut de Génétique et de Biologie Moléculaire et Cellulaire Illkirch, Illkirch, France.
Izzie-Jacques NamerUniversité de Strasbourg, Faculté de Médecine, Strasbourg, France.
Nassim Dali-YoucefInstitut de Génétique et de Biologie Moléculaire et Cellulaire Illkirch, Illkirch, France.
Inserm · FRCentre National de la Recherche Scientifique · FRHôpitaux Universitaires de Strasbourg · FRInstitut de génétique et de biologie moléculaire et cellulaire · FRMitochondrie, stress oxydant et protection musculaire · FRUniversité de Strasbourg · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anesthesiacancer progressioncancer surgerylidocainemetabolomicsonco-anesthesiaperioperative period

Identifiers

PMID35273500
PMCPMC8902240
OpenAlexW4213089354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.